Slide Insurance director sells 7,500 shares

Rhea-AI Filing Summary

Slide Insurance Holdings, Inc. (SLDE) director Stephen L. Rohde reported on September 14, 2026 exercising stock options for 7,500 shares of common stock at an exercise price of $1.38 per share, then selling 7,500 shares of common stock at $26.40 per share the same day. After the exercise, he held 35,000 stock options directly, which are described as fully vested and exercisable, with the option series expiring on July 12, 2033. No Rule 10b5-1 trading plan is reported for these transactions.

Insider Trade Summary

Exercise and Sale: 7,500 shares ($188K approx. pre-tax spread)

Exercise and Sale 3 txns

Insider ROHDE STEPHEN L

Role Director

Sold 7,500 shs ($198K)

Approx. gross sale proceeds $198K

Approx. exercise cost $10K

Approx. pre-tax spread $188K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) F1	7,500	$0.00	$0.00
Exercise	Common Stock	7,500	$1.38	$10K
Sale	Common Stock	7,500	$26.40	$198K

Holdings After Transaction: Stock Option (Right to Buy) — 35,000 contracts (Direct); Common Stock — 0 shares (Direct)

Footnotes (1)

1. F1. These stock options are fully vested and exercisable.

Key Figures

Options exercised: 7,500 shares Option exercise price: $1.38 per share Shares sold: 7,500 shares +4 more

7 metrics

Options exercised 7,500 shares Stock options for common stock exercised on September 14, 2026

Option exercise price $1.38 per share Exercise price for 7,500 stock options into common stock

Shares sold 7,500 shares Common stock sold on September 14, 2026

Sale price $26.40 per share Price per share for 7,500 common shares sold

Options held after exercise 35,000 options Director’s remaining stock options after the reported exercise

Option expiration date July 12, 2033 Expiration date for the exercised stock option series

Net common shares sold 7,500 shares Net direction from acquisition via exercise and same-day sale

Key Terms

stock options, fully vested, derivative security

3 terms

stock options financial

"These stock options are fully vested and exercisable."

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

fully vested financial

"These stock options are fully vested and exercisable."

derivative security financial

"described as an exercise or conversion of a derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did SLDE director Stephen L. Rohde report?

He reported exercising stock options for 7,500 shares of Slide Insurance Holdings, Inc. common stock at $1.38 per share and then selling 7,500 shares of common stock at $26.40 per share on September 14, 2026.

Did the SLDE director retain any options after the September 14, 2026 transactions?

Yes. After the reported exercise, Stephen L. Rohde held 35,000 stock options directly. The filing notes that these stock options are fully vested and exercisable and are scheduled to expire on July 12, 2033.

At what prices did the SLDE option exercise and share sale occur?

The stock options were exercised at an exercise price of $1.38 per share, and the resulting 7,500 common shares were sold at $26.40 per share on September 14, 2026, according to the reported transactions.

Were the Slide Insurance Holdings (SLDE) transactions under a Rule 10b5-1 plan?

No. The filing indicates that these transactions by director Stephen L. Rohde were not made pursuant to a Rule 10b5-1 trading plan, as the related affirmation checkbox is not marked as being under such a plan.

What type of securities did the SLDE director trade in this Form 4?

He exercised stock options, which are a type of derivative security granting the right to buy common stock, and then sold the underlying common stock shares obtained from the exercise.

What is the net share effect of the SLDE director’s reported trades?

The transactions show a net sell direction of 7,500 common shares: 7,500 shares were acquired through option exercise and 7,500 shares of common stock were sold, while option holdings increased in the exercised series and totaled 35,000 afterward.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 04:25 PM Accepted by SEC EDGAR 09/16/2026 - 04:25 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ROHDE STEPHEN L

(Last) (First) (Middle)

C/O SLIDE INSURANCE HOLDINGS, INC.

4221 W. BOY SCOUT BLVD., SUITE 200

(Street)

TAMPA FLORIDA 33607

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Slide Insurance Holdings, Inc. [ SLDE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/14/2026		M		7,500	A	$1.38	7,500	D
Common Stock	09/14/2026		S		7,500	D	$26.4	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$1.38	09/14/2026		M			7,500	(1)	07/12/2033	Common Stock	7,500	$0	35,000	D

Explanation of Responses:

1. These stock options are fully vested and exercisable.

	/s/ Stephen Rohde	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)